|
FNDC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.859200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.259200E-01 |
| Normal-vs-Stage2 |
1.920010E-03 |
| Normal-vs-Stage3 |
4.905200E-01 |
| Normal-vs-Stage4 |
2.215200E-01 |
| Stage1-vs-Stage2 |
1.67943999999087E-05 |
| Stage1-vs-Stage3 |
6.590600E-01 |
| Stage1-vs-Stage4 |
4.685000E-01 |
| Stage2-vs-Stage3 |
4.007100E-04 |
| Stage2-vs-Stage4 |
1.866460E-02 |
| Stage3-vs-Stage4 |
3.626200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.041000E-01 |
| Normal-vs-AfricanAmerican |
7.142000E-02 |
| Normal-vs-Asian |
2.844200E-01 |
| Caucasian-vs-AfricanAmerican |
9.650200E-02 |
| Caucasian-vs-Asian |
2.943200E-01 |
| AfricanAmerican-vs-Asian |
7.412600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.068800E-01 |
| Normal-vs-Female |
7.736200E-01 |
| Male-vs-Female |
3.137800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.328600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.917000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.517800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.202400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.511600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.803400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.522000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.579600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.551400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.112400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.723800E-01 |
| Normal-vs-Grade 2 |
9.798800E-01 |
| Normal-vs-Grade 3 |
4.988200E-01 |
| Normal-vs-Grade 4 |
1.277810E-01 |
| Grade 1-vs-Grade 2 |
6.123800E-01 |
| Grade 1-vs-Grade 3 |
2.896200E-01 |
| Grade 1-vs-Grade 4 |
8.284000E-02 |
| Grade 2-vs-Grade 3 |
4.907800E-01 |
| Grade 2-vs-Grade 4 |
1.269560E-01 |
| Grade 3-vs-Grade 4 |
2.196800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.15169999999909E-05 |
| Normal-vs-ccB subtype |
2.441900E-04 |
| ccA subtype-vs-ccB subtype |
9.74775815620887E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.900400E-01 |
| Normal-vs-N1 |
1.062020E-01 |
| N0-vs-N1 |
1.253400E-01 |
|
|
